Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for survival in patients with resectable esophageal squamous cell carcinoma (JCOG2305A).

被引：0
|
作者：
Kadota, Tomohiro
Kato, Ken
Machida, Ryunosuke
Kita, Ryosuke
Ito, Yoshinori
Kitagawa, Yuko
Daiko, Hiroyuki
Tsubosa, Yasuhiro
Nagatani, Yoshiaki
Hara, Hiroki
Minashi, Keiko
Kajiwara, Takeshi
Koyanagi, Kazuo
Ogata, Takashi
Yoshii, Takako
Fujita, Takeo
Matsuda, Satoru
Tsushima, Takahiro
Takeuchi, Hiroya
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.417
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A)
    Nomura, Motoo
    Kato, Ken
    Ando, Nobutoshi
    Ohtsu, Atsushi
    Muro, Kei
    Igaki, Hiroyasu
    Abe, Tetsuya
    Takeuchi, Hiroya
    Daiko, Hiroyuki
    Gotoh, Masahiro
    Kataoka, Kozo
    Wakabayashi, Masashi
    Kitagawa, Yuko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (06) : 480 - 486
  • [2] A retrospective analysis of neoadjuvant chemotherapy followed by surgery or definitive chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
    Nakatsumi, Hiroshi
    Komatsu, Yoshito
    Nakano, Shintaro
    Sawada, Kentaro
    Muranaka, Tetsuhito
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Uchinami, Yusuke
    Taguchi, Hiroshi
    Shirato, Hiroki
    Ebihara, Yuma
    Shichinohe, Toshiaki
    Hirano, Satoshi
    Sakamoto, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [3] Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hirohata, Ryosuke
    Hamai, Yoichi
    Hihara, Jun
    Emi, Manabu
    Kurokawa, Tomoaki
    Yoshikawa, Toru
    Ohsawa, Manato
    Kitasaki, Nao
    Okada, Morihito
    WORLD JOURNAL OF SURGERY, 2022, 46 (08) : 1934 - 1943
  • [4] Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Ryosuke Hirohata
    Yoichi Hamai
    Jun Hihara
    Manabu Emi
    Tomoaki Kurokawa
    Toru Yoshikawa
    Manato Ohsawa
    Nao Kitasaki
    Morihito Okada
    World Journal of Surgery, 2022, 46 : 1934 - 1943
  • [5] Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma
    Hui-Shan Chen
    Ching-Hsiung Lin
    Shiao-Chi Wu
    Bing-Yen Wang
    Annals of Surgical Oncology, 2022, 29 : 3617 - 3627
  • [6] Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma
    Chen, Hui-Shan
    Lin, Ching-Hsiung
    Wu, Shiao-Chi
    Wang, Bing-Yen
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3617 - 3627
  • [7] Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis
    Nomura, Motoo
    Oze, Isao
    Kodaira, Takeshi
    Abe, Tetsuya
    Komori, Azusa
    Narita, Yukiya
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kadowaki, Shigenori
    Ura, Takashi
    Andoh, Masashi
    Tachibana, Hiroyuki
    Uemura, Norihisa
    Tajika, Masahiro
    Niwa, Yasumasa
    Muto, Manabu
    Muro, Kei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (05) : 890 - 898
  • [8] Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis
    Motoo Nomura
    Isao Oze
    Takeshi Kodaira
    Tetsuya Abe
    Azusa Komori
    Yukiya Narita
    Toshiki Masuishi
    Hiroya Taniguchi
    Shigenori Kadowaki
    Takashi Ura
    Masashi Andoh
    Hiroyuki Tachibana
    Norihisa Uemura
    Masahiro Tajika
    Yasumasa Niwa
    Manabu Muto
    Kei Muro
    International Journal of Clinical Oncology, 2016, 21 : 890 - 898
  • [9] Comparison between neoadjuvant chemotherapy followed by surgery (NAC-S) and definitive chemoradiotherapy (CRT) in overall survival for patients with clinical stage II-III esophageal squamous cell carcinoma (ESCC) (JCOG1406-A)
    Nomura, Motoo
    Kato, Ken
    Mizusawa, Junki
    Kataoka, Kozo
    Ando, Nobutoshi
    Muro, Kei
    Ohtsu, Atsushi
    Igaki, Hiroyasu
    Shinoda, Masayuki
    Takeuchi, Hiroya
    Shimizu, Hideaki
    Hayashi, Kazuhiko
    Daiko, Hiroyuki
    Goto, Masahiro
    Komatsu, Yoshito
    Konishi, Kazuo
    Miyata, Yoshinori
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma
    Barbetta, Arianna
    Hsu, Meier
    Tan, Kay See
    Stefanova, Dessislava
    Herman, Koby
    Adusumilli, Prasad S.
    Bains, Manjit S.
    Bott, Matthew J.
    Isbell, James M.
    Janjigian, Yelena Y.
    Ku, Geoffrey Y.
    Park, Bernard J.
    Wu, Abraham J.
    Jones, David R.
    Molena, Daniela
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2710 - 2719
12345